Pregled bibliografske jedinice broj: 1181387
Placental and cord blood DNA methylation of the serotonin receptor type 2A gene: Modulation by fetal sex and genotype and maternal metabolic state
Placental and cord blood DNA methylation of the serotonin receptor type 2A gene: Modulation by fetal sex and genotype and maternal metabolic state // 45th FEBS Congress Abstracts
Ljubljana, Slovenija, 2021. P01.403, 1 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1181387 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Placental and cord blood DNA methylation of the
serotonin receptor type 2A gene: Modulation by
fetal sex and genotype and maternal metabolic
state
Autori
Horvatiček, Marina ; Perić, Maja ; Bečeheli, Ivona ; Klasić, Marija ; Nikolić, Barbara ; Hranilović, Dubravka ; Ivanišević, Marina ; Štefulj, Jasminka.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
45th FEBS Congress Abstracts
/ - , 2021
Skup
45th FEBS Congress “Molecules of Life: Towards New Horizons“
Mjesto i datum
Ljubljana, Slovenija, 03.07.2021. - 08.07.2021
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
serotonin receptor type 2A (HTR2A) ; DNA methylation, gestational diabetes mellitus (GDM) ; rs6311 and rs6306 genotypes
Sažetak
Serotonin receptor type 2A (HTR2A), a widely distributed Gproteincoupled receptor for multifunctional signaling molecule serotonin, has been implicated in many physiological processes and its dysregulation has been associated with a number of mental health and metabolic conditions. Different lines of evidence indicate that epigenetic modifications of the HTR2A gene play a role in molecular mechanisms through which early life environment influences development and lifelong health outcomes. The promoter region of the HTR2A gene contains a number of partially methylated cytosines that have been shown to modulate the gene's transcriptional activity. Here we investigated placental and cord blood HTR2A methylation levels in relation to fetal sex and genotype as well as maternal obesity and gestational diabetes mellitus. The study was performed on motherinfant dyads enrolled at the Clinical Hospital Center Zagreb as a part of our ongoing birth cohort study PlaNS (Placental and Neonatal Serotonin). All newborns were healthy, of normal birth weight and born at term by planned Csection. Cord blood samples were obtained via umbilical venipuncture and placental tissue samples were isolated from the fetal part of the placenta. DNA methylation levels were quantified at four CpG loci within the HTR2A promoter region using bisulfite pyrosequencing. In addition, samples were genotyped for two polymorphisms (rs6311, rs6306) in the respective gene region. The four targeted CpG cytosines were methylated to different degree in the cord blood and placental tissue. rs6311 and rs6306 genotypes as well as fetal sex were found to be significant predictors of the methylation levels in both tissues. Maternal metabolic parameters modulated placental HTR2A methylation in a sexdependent manner. Taken together, data point to a complex interaction of genetic and environmental factors influencing HTR2A methylation levels during human fetal development. Funded by HrZZ (IP2018016547).
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Projekti:
HRZZ-IP-2018-01-6547 - Utjecaj majčinog metaboličkog stanja na serotoninski sustav posteljice i neonatusa: od metilacije DNA do funkcije proteina (PLANS) (Štefulj, Jasminka, HRZZ - 2018-01) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Prirodoslovno-matematički fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Dubravka Hranilović
(autor)
Marija Klasić
(autor)
Ivona Bečeheli
(autor)
Marina Horvatiček
(autor)
Marina Ivanišević
(autor)
Jasminka Štefulj
(autor)
Barbara Nikolić
(autor)
Maja Perić
(autor)